DV Equities, LLC
13F holdings for Q2 2026 · CHICAGO, IL · filed August 14, 2026
DV Equities, LLC reported $698M in 13F securities across 107 holdings for Q2 2026, in a Form 13F filed August 14, 2026. The largest positions were iShares Core Msci Emerging Markets ETF (16.2%), SONY (7.4%), TNGX (6.0%).
- 13F value Q2 2026
- $698M
- Holdings
- 107
- Change vs prior quarter
- First report
- Rank by 13F value
- #3,187
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Top holdings
| Stock | Value | Weight | Shares | Change in shares | Move |
|---|---|---|---|---|---|
| iShares Core Msci Emerging Markets ETF | $112M | 16.2% | 1,347,857 | New | First report |
| SONY Sony Group Corporation | $50.7M | 7.4% | 2,529,344 | New | First report |
| TNGX Tango Therapeutics Inc. | $41.2M | 6.0% | 1,318,551 | New | First report |
| HMC Honda Motor Company Ltd. | $41.2M | 6.0% | 1,520,344 | New | First report |
| iShares Inc | $31.4M | 4.6% | 155,525 | New | First report |
| NVO Novo Nordisk A/S | $30.3M | 4.4% | 631,226 | New | First report |
| iShares TR | $27.2M | 3.9% | 861,599 | New | First report |
| iShares TR | $19.2M | 2.8% | 184,394 | New | First report |
| Pharvaris NV | $16.7M | 2.4% | 482,524 | New | First report |
| iShares TR | $16.1M | 2.3% | 326,711 | New | First report |
| MU Micron Technology Inc. | $15.0M | 2.2% | 13,025 | New | First report |
| Vanguard Ftse Developed Markets ETF | $14.6M | 2.1% | 204,520 | New | First report |
| iShares Inc | $11.1M | 1.6% | 392,549 | New | First report |
| iShares Inc | $10.6M | 1.5% | 100,394 | New | First report |
| GOOGL Alphabet Inc. | $10.4M | 1.5% | 29,054 | New | First report |
| DEO Diageo plc | $10.1M | 1.5% | 125,998 | New | First report |
| BP BP p.l.c. | $10.1M | 1.5% | 272,919 | New | First report |
| GSK GSK plc | $9.9M | 1.4% | 188,762 | New | First report |
| IXUS iShares Core MSCI Total International Stock ETF | $9.5M | 1.4% | 100,000 | New | First report |
| MSFT Microsoft Corporation | $9.5M | 1.4% | 25,442 | New | First report |
| RVMD Revolution Medicines Inc. | $8.9M | 1.3% | 47,666 | New | First report |
| MANE Veradermics Incorporated | $8.6M | 1.2% | 70,000 | New | First report |
| ING ING Group N.V. | $7.5M | 1.1% | 239,305 | New | First report |
| iShares TR | $7.2M | 1.0% | 50,000 | New | First report |
| SNDK Sandisk Corporation | $6.4M | 0.9% | 2,798 | New | First report |
Share positions only, at the value reported for the end of Q2 2026. Weight is the share of $690M in share positions; options and bonds count in the 13F value but not here.
Sector mix
- Not listed with us43.8%
- Health Care20.4%
- Technology9.8%
- Consumer Staples8.8%
- Industrials7.7%
- Finance3.2%
- Consumer Discretionary2.3%
- n/a1.9%
- Energy1.8%
- Real Estate0.1%
- Utilities0.1%
- Basic Materials0.1%
13F value by quarter
More holdings
| Stock | Value | Weight | Shares | Change in shares | Move |
|---|---|---|---|---|---|
| ASMB Assembly Biosciences Inc. | $6.2M | 0.9% | 226,415 | New | First report |
| AVTX Avalo Therapeutics Inc. | $6.1M | 0.9% | 332,213 | New | First report |
| LQDA Liquidia Corporation | $5.9M | 0.9% | 74,500 | New | First report |
| SAN Banco Santander S.A. Sponsored ADR (Spain) | $5.7M | 0.8% | 413,409 | New | First report |
| iShares Msci Eafe Value ETF | $5.3M | 0.8% | 69,483 | New | First report |
| BIDU Baidu Inc. ADS | $4.3M | 0.6% | 37,421 | New | First report |
| NERV Minerva Neurosciences Inc | $4.2M | 0.6% | 754,397 | New | First report |
| ERIC Ericsson | $4.1M | 0.6% | 369,959 | New | First report |
| iShares Inc Msci Hong Kong Index FD | $4.0M | 0.6% | 193,297 | New | First report |
| GLW Corning Incorporated | $4.0M | 0.6% | 15,644 | New | First report |
| BBVA Banco Bilbao Vizcaya Argentaria S.A. | $3.9M | 0.6% | 154,946 | New | First report |
| ELVN Enliven Therapeutics Inc. | $3.9M | 0.6% | 76,250 | New | First report |
| JD JD.com Inc. | $3.7M | 0.5% | 144,295 | New | First report |
| iShares Inc | $3.6M | 0.5% | 59,927 | New | First report |
| UL Unilever PLC | $3.5M | 0.5% | 58,240 | New | First report |
| Damora Therapeutics Inc | $3.4M | 0.5% | 130,000 | New | First report |
| iShares Inc Msci France ETF | $3.4M | 0.5% | 73,984 | New | First report |
| Rayliant FDS TR | $3.3M | 0.5% | 125,000 | New | First report |
| BILI Bilibili Inc. | $3.3M | 0.5% | 191,360 | New | First report |
| NTES NetEase Inc. | $3.2M | 0.5% | 25,314 | New | First report |
| NWG NatWest Group plc | $3.2M | 0.5% | 180,475 | New | First report |
| iShares Inc | $3.1M | 0.5% | 62,500 | New | First report |
| RELX RELX PLC PLC | $3.1M | 0.4% | 97,209 | New | First report |
| WDC Western Digital Corporation | $2.9M | 0.4% | 4,505 | New | First report |
| TM Toyota Motor Corporation | $2.8M | 0.4% | 16,704 | New | First report |
Showing the 50 largest of 100 share positions. The full filing on SEC EDGAR
Questions about DV Equities, LLC
- What does DV Equities, LLC own?
- In its Form 13F for Q2 2026, DV Equities, LLC reported 107 holdings worth $698M. The five largest were iShares Core Msci Emerging Markets ETF, SONY, TNGX, HMC, iShares Inc.
- What did DV Equities, LLC buy and sell in Q2 2026?
- DV Equities, LLC opened 0 new positions, added to 0, trimmed 0 and sold out of 0 compared with the quarter before.
- When did DV Equities, LLC file its latest 13F?
- Form 13F is due 45 days after each quarter ends. The Q2 2026 report was due August 14, 2026 and was filed August 14, 2026.
From Form 13F filed by DV Equities, LLC (SEC CIK 0001841659) for the quarter ended June 30, 2026, via the SEC's Form 13F data sets. Amendments that restate a report replace it; amendments that add holdings are included. View on SEC EDGAR · All funds